BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29400016)

  • 1. Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer.
    Mikami M; Shida M; Shibata T; Katabuchi H; Kigawa J; Aoki D; Yaegashi N
    J Gynecol Oncol; 2018 Mar; 29(2):e23. PubMed ID: 29400016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
    Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
    J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee.
    Ikeda M; Shida M; Shigeta S; Nagase S; Takahashi F; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
    J Gynecol Oncol; 2021 May; 32(3):e44. PubMed ID: 33825359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015.
    Yoshino K; Kurita T; Takahashi F; Nagase S;
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2584-2592. PubMed ID: 37602964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
    Komatsu H; Ikeda Y; Kawana K; Nagase S; Yoshino K; Yamagami W; Tokunaga H; Kato K; Kimura T; Aoki D; Obstetrics TCOGOOTJSO; Gynecology
    Int J Clin Oncol; 2024 Jan; 29(1):72-77. PubMed ID: 38055097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of "best practice" treatment patterns for a "radiation oncology community outreach group" engaged in cancer disparities outcomes.
    de Andrade RS; Proctor JW; Rakfal SM; Werts ED; Schenken LL; Saw CB; Dougherty M; Stefanik D
    J Am Coll Radiol; 2008 Apr; 5(4):571-8. PubMed ID: 18359445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core-curriculum in psycho-oncology: Towards the certification of the psycho-oncologist profession.
    Grassi L; Watson M;
    Psychooncology; 2024 Jan; 33(1):e6285. PubMed ID: 38282216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of the educational environment to acquire and maintain the professional skills of radiotherapy technology and medical physics specialists in Japan: a nationwide survey.
    Hayashi N; Okumura M; Nakamura M; Ishihara Y; Ota S; Tohyama N; Shimomura K; Okamoto H; Onishi H
    Radiol Phys Technol; 2023 Dec; 16(4):431-442. PubMed ID: 37668931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.
    Fotopoulou C; Eriksson AG; Planchamp F; Morice P; Taylor A; Sturdza A; Florin Coza O; Halaska MJ; Martinelli F; Armbrust R; Chargari C
    Int J Gynecol Cancer; 2024 Apr; 34(4):480-489. PubMed ID: 38395448
    [No Abstract]   [Full Text] [Related]  

  • 11. Does Cancer Accreditation Designation Mean Better Quality Care and Long-Term Oncological Outcomes?
    Joseph KA
    Ann Surg Oncol; 2024 May; 31(5):2804-2805. PubMed ID: 38252265
    [No Abstract]   [Full Text] [Related]  

  • 12. Total uterine inversion due to pedunculated vaginal tumor.
    Castillo MH; Marrufo C
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37989479
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].
    Landy R; Mathews C; Robertson M; Wiggins CL; McDonald YJ; Goldberg DW; Scarinci IC; Cuzick J; Sasieni PD; Wheeler CM;
    Gynecol Oncol; 2021 Dec; 163(3):614. PubMed ID: 34602285
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].
    Landy R; Mathews C; Robertson M; Wiggins CL; McDonald YJ; Goldberg DW; Scarinci IC; Cuzick J; Sasieni PD; Wheeler CM;
    Gynecol Oncol; 2021 Jun; 161(3):913. PubMed ID: 33867145
    [No Abstract]   [Full Text] [Related]  

  • 15. Efforts towards erasing borders in gynecologic cancer?
    Chuang LT; Randall TC; Karlan BY
    Gynecol Oncol Rep; 2017 Aug; 21():5-6. PubMed ID: 28540361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accredited practices mark B Corp month.
    Vet Rec; 2023 Mar; 192(6):242. PubMed ID: 36928975
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins.
    Chikazawa K; Imai K; Kuwata T; Konno R
    J Gynecol Oncol; 2024 May; 35(3):e28. PubMed ID: 38156721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after Diagnosis of Cervical Cancer Patients at a Tertiary Referral Hospital in Northeast Thailand.
    Wannasin R; Likitdee N; Kelly M; Thinkhamrop K
    Asian Pac J Cancer Prev; 2023 May; 24(5):1759-1767. PubMed ID: 37247299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan.
    Yoshida H; Machida H; Matsuo K; Terai Y; Fujii T; Mandai M; Kawana K; Kobayashi H; Mikami M; Nagase S
    J Gynecol Oncol; 2023 May; 34(3):e56. PubMed ID: 36929580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and patients' profile in treated stage I and II lung adenocarcinoma: a Hospital's Cancer Registry-based analysis.
    AbrĂ£o FC; Peres SV; de Abreu IRLB; Younes RN
    J Thorac Dis; 2021 Nov; 13(11):6294-6303. PubMed ID: 34992809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.